Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-052162

EVP, R&D & Chief Scientific Of sold 31,500 shares at an average $40.17 ($1,265,330)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-09-24 Sale −14,069 $39.74 $559,102 317,286 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-09-24 Sale −3,931 $40.53 $159,323 313,355 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-09-25 Sale −10,000 $40.26 $402,600 303,355 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-09-25 Sale −3,500 $41.23 $144,305 299,855 D
Open-market sales · 31,500 sh · avg $40.17 · $1,265,330
Loading xslF345X03/doc4.xml…